Literature DB >> 16059855

Reliability and validity of the DynEx dynamometer.

Orit Shechtman1, Lisa Gestewitz, Christine Kimble.   

Abstract

Abstract The purpose of the study was to examine the reliability and validity of the digital DynEx dynamometer. Grip strength testing was conducted on 100 healthy subjects (aged 20-40 years) using both the Jamar and DynEx dynamometers in the second handle position. The data were analyzed for test-retest reliability and concurrent validity using the intraclass correlation coefficient. A repeated-measures analysis of covariance was conducted to reveal differences in grip strength between instruments. In addition, measurement error was calculated with known weights. The DynEx dynamometer was found to have high test-retest reliability both with human subjects ( r = 0.9864) and with known weights suspended from the dynamometer's handle ( r = 0.9999). The DynEx dynamometers had a smaller measurement error (1.63%) than the Jamar dynamometers (7.74%). Although significant differences were found between grip scores obtained on the Jamar and the DynEx (F = 6.222; p = 0.014), the concurrent validity between the two instruments was excellent ( r > 0.98). The results of this study indicate that clinicians can use the DynEx dynamometer at the second handle position knowing that it is reliable, valid, and comparable to the second handle position of the Jamar dynamometer.

Entities:  

Mesh:

Year:  2005        PMID: 16059855     DOI: 10.1197/j.jht.2005.04.002

Source DB:  PubMed          Journal:  J Hand Ther        ISSN: 0894-1130            Impact factor:   1.950


  30 in total

1.  The efficacy of peloid therapy in management of hand osteoarthritis: a pilot study.

Authors:  Meliha Kasapoğlu Aksoy; Lale Altan; Rıza Eröksüz; Burcu Metin Ökmen
Journal:  Int J Biometeorol       Date:  2017-08-04       Impact factor: 3.787

2.  Reliability and validity of the multiaxis profile dynamometer with younger and older participants.

Authors:  Curt B Irwin; Mary E Sesto
Journal:  J Hand Ther       Date:  2010-04-24       Impact factor: 1.950

3.  Bioelectrical impedance phase angle as indicator and predictor of cachexia in head and neck cancer patients treated with (chemo)radiotherapy.

Authors:  P Stegel; N R Kozjek; B A Brumen; P Strojan
Journal:  Eur J Clin Nutr       Date:  2016-02-24       Impact factor: 4.016

4.  Effectiveness of PELOID therapy in carpal tunnel syndrome: A randomized controlled single blind study.

Authors:  Burcu Metin Ökmen; Meliha Kasapoğlu Aksoy; Aygül Güneş; Riza Eröksüz; Lale Altan
Journal:  Int J Biometeorol       Date:  2017-02-16       Impact factor: 3.787

5.  The effectiveness of the low-power laser and kinesiotaping in the treatment of carpal tunnel syndrome, a pilot study.

Authors:  A Güner; L Altan; M Kasapoğlu Aksoy
Journal:  Rheumatol Int       Date:  2018-03-28       Impact factor: 2.631

6.  Effects of Clinical Pilates Exercises on Patients Developing Lymphedema after Breast Cancer Treatment: A Randomized Clinical Trial.

Authors:  Hülya Özlem Şener; Mehtap Malkoç; Gülbin Ergin; Didem Karadibak; Tuğba Yavuzşen
Journal:  J Breast Health       Date:  2017-01-01

7.  Comparison of hand dynamometers in elderly people.

Authors:  R S Guerra; T F Amaral
Journal:  J Nutr Health Aging       Date:  2009-12       Impact factor: 4.075

8.  Reliability of the pinch strength with digitalized pinch dynamometer.

Authors:  Heesuk Shin; Seung Won Moon; Gab-Soon Kim; Jung Dong Park; Jin Hoan Kim; Mi Jin Jung; Chul Ho Yoon; Eun Shin Lee; Min-Kyun Oh
Journal:  Ann Rehabil Med       Date:  2012-06-30

9.  Short-term efficacy of paraffin therapy and home-based exercise programs in the treatment of symptomatic hand osteoarthritis.

Authors:  Meliha Kasapoğlu Aksoy; Lale Altan
Journal:  Turk J Phys Med Rehabil       Date:  2017-10-02

10.  Effectiveness of Superficial Radial Nerve Block on Pain, Function and Quality of Life in Patients With Hand Osteoarthritis: A Prospective, Randomized and Controlled Single-Blind Study.

Authors:  Burcu Metin Ökmen; Korgün Ökmen; Lale Altan
Journal:  Arch Rheumatol       Date:  2018-03-23       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.